Benzinga | May 27, 2021 07:06AM EDT

Redhill Biopharma Q1 EPS $(0.05) Beats $(0.34) Estimate, Sales $20.57M Miss $22.70M Estimate

Redhill Biopharma (NASDAQ:RDHL) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.34) by 85.29 percent. This is unchanged from the same period last year. The company reported quarterly sales of $20.57 million which missed the analyst consensus estimate of $22.70 million by 9.36 percent. This is a 1.85K percent increase over sales of $1.06 million the same period last year.